- A novel mitochondria-targeting tetrapeptide for subcellular delivery of nanoparticles
-
Mitochondrial dysfunction is associated with the emergence of several neurological and cardiovascular diseases. Hence, mitochondria-targeting delivery strategies are highly significant and critically needed. In this study, we developed a small library of peptides simulating the mitochondria-targeting peptide SS-31, a promising tetra-peptide with antioxidant character, and subsequently evaluated the toxicity, antioxidant ability and mitochondrial delivery of nanoparticles. Among the designed peptides, RF-2 (D-Arg-Dmt-Arg-Phe-NH2) showed controlled toxicity and excellent protection against gentamicin-induced hair cell damage, as compared with SS-31. More importantly, RF-2-modified PLGA nanoparticles demonstrated high colocalization with mitochondria and comparable specific subcellular accumulation, when compared with SS-31. Taken together, the obtained results supported RF-2 as a mitochondria-targeting peptide with high potential as a targeted carrier.
- Sun, Yanhui,Zhan, Aiyan,Zhou, Shuang,Kuang, Xiao,Shen, Hongyan,Liu, Hongzhuo,Xu, Youjun
-
-
Read Online
- Methods and Compositions for Delivery of Biotin to Mitochondria
-
Certain exemplary embodiments are directed to a biologically active composition of matter (and uses thereof) configured for targeted delivery of biotin to mitochondria, the composition comprising a first D-biotin conjugated to a water-soluble, cell-permeable, peptide sequence, wherein the peptide sequence is selected from a polypeptide group with an alternating aromatic-cationic motif.
- -
-
Page/Page column 22
(2022/03/19)
-
- TETRAPEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME
-
The present invention is to provide a method for the efficient production on an industrial scale of SS-31 (D-Arg-Dmt-Lys-Phe-NH2), which is an SS peptide. According to the present invention, the desired SS-31 is produced by efficiently synthesizing a tetrapeptide compound as a precursor of SS-31 and improving the tetrapeptide purity by crystallization.
- -
-
Paragraph 0093; 0094
(2016/10/04)
-
- PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES
-
The present technology provides methods of generating the peptides, and pharmaceutically acceptable salts of the peptides and intermediates thereof. In some embodiments, the peptide is D-Arg-2′6′-Dmt-Lys-Phe-NH2.
- -
-
-